Synthesis and study of a dipyridamole prodrug: Application of the ADEPT strategy to the MDR resistance in cancer chemotherapy;Synthèse et étude d'une prodrogue de dipyridamole: Application de la stratégie ADEPT à la résistance multiple (MDR) en chimiothérapie anticancéreuse

Comptes Rendus de l'Academie des Sciences - Series IIc: Chemistry

Volumn 1, Issue 7, 1998, Pages 421-424

  Schmidt, Frédéric ^a   Florent, Jean Claude ^a   Monneret, Claude ^a  

^a CNRS   (France)

Author keywords

ADEPT; b glucuronidase; Cancer; Dipyridamole; Doxorubicin; Multidrug resistance; Prodrug

Indexed keywords

EID: 0032116951     PISSN: 13871609     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1387-1609(98)80422-2     Document Type: Article

References (10)

1. [1] Bagshawe K.D., Br. J. Cancer 56 (1987) 531-532.
2. [2] Bagshawe K.D., Drug Development Research 34 (1995) 220-230.
3. [3] Sherwood R.F., Advanced Drug Delivery Reviews 22 (1996) 269-288.
4. [4] Koch M., Monneret C., Recent Res. Devel. in Chem. & Pharm. Sciences 1 (1996) 35-47.
5. [5] Schmidt F., Florent J.-C., Monneret C., Straub R., Czech J., Gerken M., Bosslet K., Bioorg. Med. Chem. Lett. 7 (1997) 1071-1076.
6. [6] Jacquesy J.-C., Gesson J.-P., Monneret C., Mondon M., Renoux B., Florent J.-C., Koch M., Tillequin F., Sedlacek H.S., Gerken M., Kolar C., Gaudel G., Bosslet K., Czech J., Hoffman D., Seemann G., Schorlemmer H.-U., Dickneite G., U.S. Patent 5,561,119, déposée le 1.10.96.
7. [7] Gottesman M., Cancer Res. 53 (1993) 747-754.
8. [8] Van der Bliek A.M., Borst P., Adv. Cancer Res. 52 (1989) 165-203.
9. [9] Robert J., Drugs of the Future 22 (1997) 149-158.
10. [10] Desai P. B., Duan J., Sridhar R., Damle B.D., Methods Find. Exp. Clin. Pharmacol. 19(4) (1997) 231-239.